Literature DB >> 15493244

ADA-based accommodations in higher education: a survey of clinicians about documentation requirements and diagnostic standards.

Michael Gordon1, Lawrence Lewandowski, Kevin Murphy, Kim Dempsey.   

Abstract

The expansion of the number of students requesting accommodations in postsecondary settings compels clinicians to become knowledgeable about the legal definitions and documentation requirements of the Americans with Disabilities Act (ADA). Because the law is relatively new, courts and regulatory agencies have only recently begun to clarify what constitutes a disability. In this study, 147 clinicians completed a questionnaire developed to assess their understanding of the law and the diagnostic approaches they used to justify claims of learning disability (LD), attention-deficit/hyperactivity disorder (ADHD), and psychiatric disability. Whereas the clinicians agreed on certain points (e.g., the right of institutions to formulate specific policies regarding documentation), they substantially disagreed on several fundamental issues. Clinician consensus was lowest on items that asked about the basic intent of the law, the metrics for assessing impairment, and the criteria for assessing ADHD in adulthood. Judged against the legislative history of the ADA and the body of regulatory rulings and legal decisions, many clinicians' responses showed a need for clarification regarding the distinction between special education law and the antidiscrimination intent of the ADA. The respondents also expressed a nearly uniform wish for more training in this fast-growing area of clinical practice.

Entities:  

Mesh:

Year:  2002        PMID: 15493244     DOI: 10.1177/00222194020350040601

Source DB:  PubMed          Journal:  J Learn Disabil        ISSN: 0022-2194


  1 in total

1.  Comparing Age- and Grade-Based Norms on the Woodcock-Johnson III Normative Update.

Authors:  Allyson G Harrison; Kaitlyn Butt; Irene Armstrong
Journal:  Educ Psychol Meas       Date:  2019-03-12       Impact factor: 2.821

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.